Eliana Clark - 01 Mar 2026 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Reporting relationship: EVP, Chief Technical Officer
Issuer ticker: NTLA
Reported as of: 01 Mar 2026
Net transaction value: -$8,364
SEC form: 4
Accepted by SEC: 03 Mar 2026, 16:16:13 UTC
Prior SEC filing: 07 Jan 2026
Source filing: View source filing
Reporting owner signature: James Basta, attorney-in-fact

Key filing fact

Eliana Clark filed Form 4 for Intellia Therapeutics, Inc. (NTLA) on 03 Mar 2026.

Key facts

This page summarizes Eliana Clark's Form 4 filing for Intellia Therapeutics, Inc. (NTLA).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2026, 16:16.

Change

Previous filing in this sequence was filed on 07 Jan 2026.
Current net transaction value: -$8,364.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001914448 Primary reporting owner

Clark Eliana

Relationship: EVP, Chief Technical Officer
Address: C/O INTELLIA THERAPEUTICS, INC., 40 ERIE STREET; SUITE 130, CAMBRIDGE
Signature: James Basta, attorney-in-fact
Signature date: 03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NTLA transaction

Common Stock

Award

Transaction value: $0
Shares: +7,353
Change %: +8.4%
Price: $0.000000
Shares after: 94,471
Date: 01 Mar 2026
Ownership: Direct
Footnotes: F1

NTLA transaction

Common Stock

Sale

Transaction value: $8,364
Shares: -607
Change %: -0.64%
Price: $13.78
Shares after: 93,864
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NTLA transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +10,505
Change %
Price: $0.000000
Shares after: 10,505
Date: 01 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,505
Exercise price: $13.78
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

Footnote F2

Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on March 1, 2026, and does not represent a volitional trade by the Reporting Person.

Footnote F3

This option was granted on March 1, 2026 with respect to shares of Common Stock, with 33% vesting on January 1, 2027 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.